yup, I think the max they used was 0.03% and 1% for the IIa trial, clearly not enough.
My guess is they saw some kind of result, especially in the 1% but felt the dose needed to be much higher in order to spend the major dollar amount it costs to go into the Phase III trials+release etc.
My guess is they saw some kind of result, especially in the 1% but felt the dose needed to be much higher in order to spend the major dollar amount it costs to go into the Phase III trials+release etc.
Comment